Sign in

Global Antibiotic R&D Partnership (GARDP)

@gardp.bsky.social
489 followers 81 following 607 posts

Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR). gardp.org/this-is-big

PostsRepliesMedia
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 1h
Lord Darzi hosted a working lunch at the House of Lords this week, convened with GARDP, in his new role as GARDP Advocate. Guests from Parliament, government, the NHS, research and industry discussed AMR resilience, financing and partnership. #AMR
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 08/10/2026
📢 We’re hiring ! Join GARDP to lead strategy and delivery across R&D, access and partnerships, advancing new and existing antibiotics for serious bacterial infections. 🔗 apply.workable.com/gardp/j/A112... #Hiring #GARDP #AMR
111
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 07/10/2026
At the 63rd PAHO Directing Council, Member States approved the Plan of Action on AMR 2027–2031. GARDP and PAHO’s work on surveillance, diagnostics, Reserve antibiotic access and R&D supports the Plan’s priorities. We look forward to contributing to its implementation. 🔗https://tinyurl.com/yvs8ryxd
110
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 06/10/2026
New gonorrhoea treatments need a clear pathway from evidence to policy and practice. At #IUSTI2026, GARDP and partners will discuss the evidence needed to guide responsible introduction and maximise public health impact. 📍 South Hall 2A 📅 16 Oct, 13:00–14:25 #AMR
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 03/10/2026
🤝In 2026, #REVIVE welcomes 19 new experts to its global community, bringing expertise across infectious diseases, microbiology, epidemiology, drug discovery, clinical research, regulatory affairs and #AMR. Different expertise. Diverse perspectives. One shared commitment: tackling AMR.
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 02/10/2026
What if antibiotic access focused not on overuse vs underuse, but optimal use? 📅Join GARDP on 27 Oct, 12:00 PM CET to explore how effective treatments can reach high-burden populations and lessons from zoliflodacin’s Thailand approval. 🔗 Register: tinyurl.com/3xfm77hc @advance-id.bsky.social
122
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 01/10/2026
@escmid.bsky.social I @lifearc.bsky.social I @carb-x.bsky.social I @bostonu.bsky.social
010
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 01/10/2026
🌍 “Innovation doesn’t happen in silos.” At #GAMRIC2026 in Lisbon, Peter Beyer reflects on why GARDP supports this conference: creating space to exchange ideas, find partners and connect work across the @=#AMR field. Next stop: 📍Bangalore, India 📆7–9 Sept 2027
100
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 29/09/2026
🤝 GARDP and @dndi.org are pleased to announce support from the Foundation for the Adaptation of International Geneva to strengthen collaboration, share capabilities and resources, and help both focus more on developing and ensuring access to treatments for NTDs and drug-resistant infections.
122
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 28/09/2026
🌎 For the first time, GARDP is participating in the PAHO Directing Council, joining health authorities from across the Americas to discuss shared public health priorities. 💊Our work with PAHO is strengthening AMR surveillance, research and antibiotic access. 🎥See the work taking shape in LatAm.
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 22/09/2026
🚀 #GAMRIC2026 kicks off in Lisbon For the next three days, people working across #AMR are coming together to talk about what is changing in the science, where the gaps remain, and what it will take to develop better tools against AMR. Come meet the team!
010
Reposted by Global Antibiotic R&D Partnership (GARDP)
ESCMID @escmid.bsky.social · 21/09/2026
#GAMRIC2026 starts tomorrow! We are excited to welcome you to Lisbon, Portugal and hope you enjoy the innovative programme and opportunities to connect. Follow along over the next days as we cover highlights from the conference. LifeArc CARB-X Global Antibiotic R&D Partnership (GARDP)
151
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 18/09/2026
#ACC2027 registration & abstract submissions are open! Join the free, virtual conference on #AMR jointly organised by @bsacandjac.bsky.social and GARDP with @eupohamr.bsky.social as collaborating organization for 2027. 🔗Register: tinyurl.com/mr2bftrv 👉Submit an abstract: tinyurl.com/bddwc49x
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 17/09/2026
In Brazil, GARDP & Fiocruz are working with hospitals & labs to understand resistance profiles for the responsible use of Reserve antibiotics, including susceptibility to cefiderocol. Microbiologists recently trained at Fiocruz’s LABSUR for training in antimicrobial susceptibility testing.
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 16/09/2026
@escmid.bsky.social I @lifearc.bsky.social I @carb-x.bsky.social I @bostonu.bsky.social
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 16/09/2026
1 WEEK TO GO | #GAMRIC2026 🗓️22–24 Sept 2026 📍Lisbon, Portugal In one week, researchers, academics and industry experts from around the world will meet at the 2nd Global AMR Innovators Conference (GAMRIC) 2026 to explore innovations addressing #AMR. 🔗Register now: www.gamric.org/registration...
120
Reposted by Global Antibiotic R&D Partnership (GARDP)
Medicines for Malaria Venture (MMV) @mmv.org · 14/09/2026
Does your organization have insights into how AI can improve clinical trial design and documentation? MMV, @dndi.org and @gardp.bsky.social are mapping AI solutions for clinical study design, operations and medical writing. Submission deadline: 7 October Learn more: bit.ly/3UMwkeW
022
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 15/09/2026
#FungalAwarenessWeek2026 | 2 days to go! Join #REVIVE on 17 Sept for our webinar exploring newer azoles, extended dosing, long half-life echinocandins and novel antifungals, with a live Q&A. attendee.gotowebinar.com/register/754...
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 14/09/2026
In lab testing, the combination of flomoxef and fosfomycin was predicted to stop 9 in 10 drug-resistant bacterial isolates, supporting further evaluation of potential carbapenem-sparing options.
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 14/09/2026
Newly published GARDP-sponsored research offers encouraging evidence for expanding treatment options for newborns with sepsis. 🔗 pubmed.ncbi.nlm.nih.gov/42705380/ #AMR #GARDP
pubmed.ncbi.nlm.nih.gov
In vitro activity of flomoxef, fosfomycin and amikacin versus a global panel of third-generation cephalosporin-resistant Enterobacterales and prediction of their ability in pairwise combinations to work as carbapenem-sparing regimens - PubMed
The results confirm the potential of these combinations as carbapenem-sparing treatments and provide additional evidence to support the evaluation of these combinations in the neonatal sepsis trial that is sponsored by GARDP (ISRCTN48721236).
101
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 13/09/2026
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 13/09/2026
On #WorldSepsisDay, we’re reminded that treating sepsis depends on having antibiotics that work. As resistance grows, those options are shrinking. “Invest in Sepsis – Save Lives” means investing in the treatments we need to stay ahead. #AMRIsBig #OurResponseIsBigger
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 11/09/2026
In Germany, earlier diagnosis helps patients receive treatment for sepsis sooner, but AMR is making infections harder to treat. Peter Beyer writes in Tagesspiegel Background on why sepsis investment must include new antibiotics: tinyurl.com/3pt7tama #WorldSepsisDay #AMRIsBig #OurResponseIsBigger
gardp.org
Sepsis: A race against time – and against resistance. – GARDP
11 September 2026 Published in the Tagesspiegel Background By Peter Beyer, Deputy Executive Director, the Global Antibiotic Research & Development Partnersh
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 11/09/2026
Personalized phage therapy has strong biological promise. But making it part of routine #AMR care will depend on stronger infrastructure. A new #REVIVE viewpoint explores what it will take to scale. 🔗https://tinyurl.com/53y2pf54
131
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 09/09/2026
💻 Register for #REVIVE’s 29 Sept webinar on clinical trial evidence shaping antibiotic use. ⏰29 Sept | 13:30 - 15:00 CEST attendee.gotowebinar.com/register/261... @jesusrbano.bsky.social I @clarityinitiative.bsky.social
121
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 08/09/2026
STARTING 🔜 Join the #WorldSepsisDay webinar exploring how neonatal antimicrobial stewardship can improve antibiotic use today and help protect treatment options for tomorrow. GARDP’s Justin Green will be joining the expert discussion.
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 08/09/2026
The trial was sponsored by @pentafoundation.bsky.social and led by @innovative-ctu.bsky.social in partnership with @citystgeorges.bsky.social, Wits Health Consortium & partners, and funded through EDCTP2 programme.
010
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 08/09/2026
New in @thelancet.com: the PediCAP trial brings important evidence on treating severe community-acquired pneumonia in young children in African hospitals. The trial used a novel design to examine IV-to-oral antibiotic step-down, antibiotic choice and more. 🔗 www.thelancet.com/journals/lan...
thelancet.com
Oral step-down, optimal drug, and total duration of antibiotic treatment in African children hospitalised with severe community-acquired pneumonia (PediCAP): a factorial randomised controlled trial
For sub-Saharan African children hospitalised with severe CAP without complicating factors, a strategy of stepping down upon clinical improvement to oral amoxicillin after initial intravenous antibiot...
133
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 07/09/2026
Journalist Md Zahid Hossain Khan investigates AMR in Bangladesh’s ICUs and NICUs in a new Daily Sun feature. The story is part of GARDP’s first-ever #WithoutBordersMediaFellowship, supporting in-depth AMR reporting across South Asia. 🔗Read the full article here: www.daily-sun.com/health/89640...
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/09/2026
This World Sexual Health Day, #EveryBody reminds us that everybody, and every body, should have the right to sexual health, rights and justice. That also means making sure everyone can access effective treatment(s) when they need it.
010
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 04/09/2026
What does a new antibiotic have to do with sexual health? More than you might think. As gonorrhoea becomes harder to treat, impact can reach reproductive health, pregnancy and newborns. That makes antibiotic innovation part of sexual health. 🦠 #AMRIsBIG #OurResponseIsBIGGER
230
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 02/09/2026
📅 Save the date: 9–11 Feb 2027 The #ACC2027 is a free, open-access virtual conference, jointly organised by @bsacandjac.bsky.social and GARDP within the framework of the @eupohamr.bsky.social. More info coming soon! 🌐Explore the website: acc-conference.com
024
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 01/09/2026
Developing a new antibiotic is only half the race. 🌍 But it's equally important that treatments reach the countries and communities with the greatest need, without unnecessary delays. 💊At GARDP, we believe antibiotic innovation and access must go hand in hand in the fight against #AMR.
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 31/08/2026
Learn how public-private partnerships help facilitate drug development, advance research, provide financing and share risks in this REVIVE Encyclopaedia video featuring Clara Maure from GARDP. 🎥 revive.gardp.org/resource/pub... #AMR #REVIVE
revive.gardp.org
Public-private partnership (PPP)
A public-private partnership (PPP) is defined as a collaborative agreement between a public sector entity and a private party to manage, advance, or finance a project with public value. PPPs are typ...
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 28/08/2026
What would happen if antibiotics stopped working? In a recent interview with GARDP, Dr. Norio Ohmagari discusses the growing threat of AMR, the challenges facing antibiotic development and the importance of global collaboration. 🔗Read the full interview: gardp.org/healthcare-i...
gardp.org
“Healthcare itself may cease to function” – GARDP
Dr. Norio Ohmagari on Japan’s AMR crisis and global challenges Dr. Norio Ohmagari is an infectious disease specialist and medical doctor. He serves as Director
021
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 27/08/2026
🎙️Join us for AMR Discussions Webinar - Breaking the resistance: Empowering the next generation of antimicrobial researchers. 📅3 Sept | 🕒15:00–16:00 CEST Explore the shortage of specialised antimicrobial researchers & solutions to attract & retain talent. 👉 register.gotowebinar.com/register/298...
030
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 26/08/2026
🦠 AMR is BIG. Our response is BIGGER. Because antibiotic R&D should serve every generation.
010
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 26/08/2026
👶 A bigger response means putting children first Too often, children wait for evidence to guide antibiotic treatment. Together with @pentafoundation.bsky.social, we're helping close the evidence gap for children and ensure they are part of antibiotic development from the start.
220
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 26/08/2026
By pooling expertise and resources, we’re building a more connected, efficient model to develop and deliver the treatments the world needs.
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 26/08/2026
swissinfo.ch takes a closer look at the strategic collaboration between @dndi.org, @mmv.org and GARDP as the global health landscape changes. 🔗Read here: www.swissinfo.ch/eng/new-trea...
110
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 25/08/2026
On #WorldSepsisDay, join experts exploring how antimicrobial stewardship can strengthen neonatal care, improve antibiotic use and help address AMR. GARDP’s Justin Green will join the discussion. 📅 8 Sept | 3pm EAT | 1pm WAT | 1pm BST | 8am EDT 🔗 newborntoolkit.org/webinars/wor...
020
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 25/08/2026
GARDP & the South African Medical Research Council recently convened experts in Cape Town to help shape GARDP's Strategic Plan 2027-31. The discussion focused on South African priorities for developing & improving access to much-needed antibiotic treatments in the region. @samrcza.bsky.social
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 23/08/2026
@escmid.bsky.social I @lifearc.bsky.social I @carb-x.bsky.social I @bostonu.bsky.social
010
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 23/08/2026
⏳ One month to go until #GAMRIC2026! Join the global AMR community in Lisbon for three days of discussions on breakthroughs in therapeutics, diagnostics, vaccines and preventatives addressing AMR. 📍 Lisbon, Portugal 📅 22–24 September 🔗 www.gamric.org
141
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 21/08/2026
🎙️ Join our AMR Discussions webinar on 3 Sept (14:30-15:30 CEST) As expert researchers leave or retire, how can we attract and retain the talent needed to secure the future of antibiotic development? 🔗Register: attendee.gotowebinar.com/register/298...
163
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 19/08/2026
🌍 Since 2018, REVIVE has helped bring together researchers from clinical, industry and academic settings to share expert #AMR knowledge. 📚 Through a growing library of free resources, REVIVE supports early-stage antimicrobial researchers. 🌐Explore everything #REVIVE has to offer: revive.gardp.org
041
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 18/08/2026
📝 New in STAT: What if the global antibiotic crisis isn’t just about overuse, but underuse too? New research in @thelancet.com points to overuse in some parts of the world and underuse in others. Peter Beyer explores what this means for access and stewardship. 🔗 www.statnews.com/2026/08/18/a...
141
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 17/08/2026
2025 marked a defining year for us. From the 1st regulatory approval in our portfolio with the US FDA approval of zoliflodacin, progress on neonatal sepsis, access initiatives & the 5 BY 25 initiative culmination, it captures how a public health-driven model is helping reshape antibiotic innovation.
000
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 17/08/2026
📖Have you read GARDP's Annual Report 2025 yet? Read how GARDP is turning vision into reality, and why the journey is far from over. 🔗Read the report: gardp.org/annual-repor... #AnnualReport #AMR #AntimicrobialResistance #GlobalHealth #GARDP
120
Global Antibiotic R&D Partnership (GARDP) @gardp.bsky.social · 14/08/2026
@drandes.bsky.social
000